Ennis & Ennis, P.A.

Ennis & Ennis, P.A. Explains Actos is Essentially a “Last Ditch Effort” Medication in Europe Due to Its Risk of Bladder Cancer

Ennis & Ennis, P.A. Explains the Recent Recall and Outlines the Recommendations to Patients Affected

Ennis & Ennis, P.A. Supports the House Democrat’s Position in Strengthening Medical Device FDA Regulations

Ennis & Ennis, P.A. Explains That Patients with Metal-on-Metal Hip Implants May Suffer Damage Without Even Realizing It

Ennis & Ennis, P.A. Explains the FDA Recall of Metal Hip Socket Device Utilized in Hip Replacement Surgery

Ennis & Ennis, P.A. Outlines FDA’s Recommendations to Women Who Take Yaz or Yasmin

Ennis & Ennis, P.A. Explains the Risks Associated with Drospirenone-Containing Birth Control Pills

Ennis & Ennis, P.A. Explains European Restrictions Placed on the Heart Drug, Multaq

Ennis & Ennis, P.A. Warns of the Risks Associated with Patients Communicating with One of the Largest Insurance and Claims Adjusters with Regards to Defective DePuy Hip Product

Ennis & Ennis, P.A. Explains that States with a Statute of Limitations of More Than One Year for Product Liability Cases May Still Have Time to File Claims Arising from the Use of Avandia